PR Newswire: news distribution, targeting and monitoring
2013
See more news releases in Legal Issues  | Legal Issues

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Questcor Pharmaceuticals, Inc. (QCOR), OCZ Technology Group, Inc. (OCZ), Ubiquiti Networks, Inc. (UBNT) and Peregrine Pharmaceuticals, Inc. (PPHM)

Share with Twitter Share with LinkedIn

NEW YORK, Oct. 15, 2012 /PRNewswire/ -- 

Questcor Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between April 26, 2011 and September 21, 2012.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

For more information, click here: http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26, 2012 to request that the Court appoint you as lead plaintiff.

OCZ Technology Group, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the ND of California on behalf of investors who acquired OCZ Technology Group, Inc. (NASDAQ: OCZ) securities between July 10, 2012 and October 10, 2012.

For more information, click here: http://zlk.9nl.com/OCZ. You have until December 11, 2012 to request that the Court appoint you as lead plaintiff. 

Ubiquiti Networks, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the US District Court for the Northern District of California on behalf of investors who purchased Ubiquiti Networks, Inc. (NASDAQ: UBNT) stock between October 14, 2011 and August 9, 2012.

For more information, click here: http://zlk.9nl.com/ubnt. You have until November 6, 2012 to request that the Court appoint you as lead plaintiff.

Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who acquired Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities between August 30, 2012 and September 26, 2012.

For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm.  You have until November 27, 2012 to request that the Court appoint you as lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004            
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP



RELATED LINKS
http://www.zlk.com

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 
Advanced Search
Search
  
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire